Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Hematologic Neoplasms 2Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Leukemia 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Colorectal Neoplasms 1Cardiotoxicity 1Carcinoma, Merkel Cell 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Exercise Test × Clear all
NCT07474090 2026-06-01

STEPS-BC

Wake Forest University Health Sciences

Phase NA Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT05036252 2025-09-30

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Memorial Sloan Kettering Cancer Center

Active not recruiting
23 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡